interior-banner-1
For Investigators 2
 

ANNOUNCING THE LOI’S FOR THE NEXT ROUND OF THE ENDURING HEARTS & AMERICAN HEART ASSOCIATION COLLABORATIVE SCIENCES AWARDEES FOR PEDIATRIC HEART TRANSPLANTATION WILL OPEN 7/1/21.
THE DEADLINE FOR LOI’S WILL BE 10/1/21*
THE LINK WILL BE PROVIDED SHORTLY

 

We are excited to announce the first two awardees of the $3M joint research collaboration between Enduring Hearts and AHA.

Congratulations

  • Dr. Christopher Almond, Dr. Kevin Daly and Meghna Patel for receiving funding for “Clinical Ancillary Study to the TEAMMATE trial”
  •  
  • Dr. James Martin, Dr. Diwakar Turaga, and Dr.Iki Adachi on the selection of their study “Early Detection of Cardiac  Allograft Vasculopathy in Post-Transplant Hearts via Single-Cell Genomics”

https://newsroom.heart.org/news/scientists-in-california-texas-to-study-ways-to-help-children-receiving-heart-transplants

 

 

ENDURING HEARTS/ISHLT TRANSPLANT LONGEVITY RESEARCH AWARD

Enduring Hearts is proud to announce the winner of the 2020 Transplant Longevity Award, Dr. Christian Heim,  Department of Cardiac Surgery, University Erlangen
Krankenhausstr for his study to explore the use of an off-label drug for the treatment of CAV. “Antiproliferative treatment options for chronic rejection after heart transplantation”

 

ENDURING hearts/ phts Racial equality & disparities research grant 

Enduring Hearts recognizes the importance of understanding how race plays a role in health outcomes for children, and this year has highlighted so many inequalities in society. While pediatric heart transplantation impacts all children, studies show that racial disparities exist specifically in mortality rates of non-white children with CHD’s as well for those who are waiting for a transplant. In response, Enduring Hearts has partnered with the Pediatric Heart Transplant Society to fully fund an investigative study to examine these healthcare inequalities and importantly devise mechanisms to address these issues. 

 

 

Congratulations to Dr. Shahnawaz Amdani and Dr. Alfred Asante-Korang from the Cleveland Clinic on receiving this grant for their study “The Impact of Community Risk Factors on Outcomes for Children Following Heart Transplantation”

ENDURING HEARTS DIRECT GRANT

The Enduring Hearts funds research aimed at our targeted research priorities listed below. For specific details about the grant program, contact: 
Csalvador@enduringhearts.org

Enduring Hearts Grant Process

For Grant consideration for 2021, please submit by 8/15/21

Check back periodically for updates on our new direct grant opportunities.

NEW ENDURING HEARTS AND ADDITIONAL VENTURES GRANT ANNOUNCEMENT

Enduring Hearts in partnership with Additional Ventures is announcing new funding to stimulate innovative research focusing on identifying, reducing and eliminating pre and post-transplant risk factors that affect outcomes of children born with complex congenital heart disease including single ventricle heart defects.

Congratulations to Kurt Schumacher, MD MS & Melissa Cousino, PhD of the University of Michigan as well as David Rosenthal, MD of Stanford University on being selected as recipients of this grant! 

Click here for more information or to review the RFP.

For questions or to learn more about this grant, please contact grants@enduringhearts.org

OUR FUNDING focus

Enduring hearts funds innovative, cutting-edge pediatric heart transplant research targeted but not limited to the following focal areas:

Transplant Longevity – Identification of early, accurate onset of rejection, development of non-invasive methods to detect rejection, strategies, and techniques to improve long-term graft survival.
Technology Application – Development of new technologies or technological applications that would improve the care and outcomes of transplant recipients
Transplant Immunology – Research and development of novel immunotherapies, identification of novel targets, improving the side-effect profiles of these agents, as well as better monitoring and measurement of immunosuppression.
Organ Matching – Strategies and innovations that would allow better organ matching and allocation.

Nutrition and Exercise Physiology –Development of evidence for pediatric heart recipient nutrition and exercise guidelines that improve the long-term outcomes of pediatric heart transplant recipients.
Medication Adherence –

Development of evidence-based strategies to improve adherent behaviors, including medication compliance, especially in adolescent recipients.

Education – Improving patient and family education, related to transplantation.
Pre-Transplant Strategies – Utilizing the latest innovations or new technologies that would improve outcomes for children leading up to and after they receive a heart transplant.

Additional weighting is afforded to those research studies that have the potential to translate within the next five years, directly involves pediatric heart transplant recipients and their families and would promote the standardization of post-transplant care.

SIGN UP FOR OUR NEWSLETTER

Save Lives as an
Organ Donor

Enduring Hearts Inc.
is a Registered 501(c)(3)
Charity EIN 46-2665745

info@enduringhearts.org
(240) EHEART-1
3600 Dallas Highway, Suite 230-350
Marietta, GA 30064